<DOC>
	<DOCNO>NCT00402454</DOCNO>
	<brief_summary>To evaluate adherence safety three regimen chemoprophylaxis tuberculosis ( TB ) HIV-infected patient positive tuberculin skin test .</brief_summary>
	<brief_title>Evaluation Three Regimens Chemoprophylaxis Tuberculosis Patients co-Infected HIV Mycobacterium Tuberculosis</brief_title>
	<detailed_description>DESINGS : We perform randomise , comparative open clinical assay carry 316 HIV-infected patient . The patient randomly assign one three regimen , 108 isoniazid six month ( 6H ) , 103 rifampin isoniazid three month ( 3RH ) , 105 pyrazinamide rifampin two month ( 2RZ ) . RESULTS : The TB rate ( case per 100 persons/year ) three treatment group 3.4 6H , 4.5 3RH 1.9 2RZ . The relative risk TB 6H compare 2RZ 1.76 , 3RH , 2.34 . Twenty-seven percent patient voluntarily abandon chemoprophylaxis 9.7 % withdrawn due adverse side-effects . Seven patient withdraw due hepatotoxicity ( 5 6H , 2 3RH 0 2RZ ) . No appreciable difference find among three regimen . CONCLUSION : In study 2RZ regimen safe 6H 3RH regimen . We observe high incidence hepatotoxicity patient receive 2RZ .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Pyrazinamide</mesh_term>
	<criteria>HIV infection confirm ELISA Western blot Age 18 65 year Life expectancy great two year Reactivity PPD &gt; 5 mm Presence active tuberculosis Background previous antituberculosis therapy chemoprophylaxis Presence symptom sign suggest pulmonary extrapulmonary tuberculosis History hypersensitivity drug use study ( isoniazid , rifampin pyrazinamide ) Aspartateaminotransferase and/or alanineaminotransferase plasma concentration equal four time normal value , total bilirubin 2 mg/ml , and/or creatinine 2 mg/ml Pregnancy Undergoing treatment incompatible drug use study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>HIV</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>AIDS</keyword>
</DOC>